Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Cited In for PubMed (Select 18042692)

1.

Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies.

Moni MA, Liò P.

BMC Bioinformatics. 2014 Oct 24;15:333. doi: 10.1186/1471-2105-15-333.

2.

The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

Vaccher E, Serraino D, Carbone A, De Paoli P.

Oncologist. 2014 Aug;19(8):860-7. doi: 10.1634/theoncologist.2014-0024. Epub 2014 Jun 26. Review.

PMID:
24969164
3.

A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?

Gupta RK, Marks M, Edwards SG, Smith K, Fletcher K, Lee SM, Ramsay A, Copas AJ, Miller RF.

PLoS One. 2014 Feb 4;9(2):e87442. doi: 10.1371/journal.pone.0087442. eCollection 2014.

4.

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.

Bollard CM, Gottschalk S, Torrano V, Diouf O, Ku S, Hazrat Y, Carrum G, Ramos C, Fayad L, Shpall EJ, Pro B, Liu H, Wu MF, Lee D, Sheehan AM, Zu Y, Gee AP, Brenner MK, Heslop HE, Rooney CM.

J Clin Oncol. 2014 Mar 10;32(8):798-808. doi: 10.1200/JCO.2013.51.5304. Epub 2013 Dec 16.

5.

B cell lymphoma in HIV transgenic mice.

Curreli S, Krishnan S, Reitz M, Lunardi-Iskandar Y, Lafferty MK, Garzino-Demo A, Zella D, Gallo RC, Bryant J.

Retrovirology. 2013 Aug 28;10:92. doi: 10.1186/1742-4690-10-92.

6.

Levels of murine, but not human, CXCL13 are greatly elevated in NOD-SCID mice bearing the AIDS-associated Burkitt lymphoma cell line, 2F7.

Widney DP, Olafsen T, Wu AM, Kitchen CM, Said JW, Smith JB, Peña G, Magpantay LI, Penichet ML, Martinez-Maza O.

PLoS One. 2013 Aug 2;8(8):e72414. doi: 10.1371/journal.pone.0072414. Print 2013.

7.

Penicillium marneffei presenting as an immune reconstitution inflammatory syndrome (IRIS) in a patient with advanced HIV.

Hall C, Hajjawi R, Barlow G, Thaker H, Adams K, Moss P.

BMJ Case Rep. 2013 Jan 28;2013. pii: bcr2012007555. doi: 10.1136/bcr-2012-007555.

8.

Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications.

de la Cruz-Merino L, Lejeune M, Nogales Fernández E, Henao Carrasco F, Grueso López A, Illescas Vacas A, Pulla MP, Callau C, Álvaro T.

Clin Dev Immunol. 2012;2012:756353. doi: 10.1155/2012/756353. Epub 2012 Aug 15. Review.

9.
10.

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.

Jacobson CA, Abramson JS.

Adv Hematol. 2012;2012:507257. doi: 10.1155/2012/507257. Epub 2012 Jan 5.

11.

Lymphoproliferative Lesions in the Setting of HIV Infection: A Five-Year Retrospective Case Series and Review.

Mahe E, Ross C, Sur M.

Patholog Res Int. 2011 Mar 30;2011:618760. doi: 10.4061/2011/618760.

12.

Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus.

Molloy MJ, Zhang W, Usherwood EJ.

J Immunol. 2011 Jun 1;186(11):6218-26. doi: 10.4049/jimmunol.1003812. Epub 2011 Apr 29.

13.

Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma.

Widney DP, Gui D, Popoviciu LM, Said JW, Breen EC, Huang X, Kitchen CM, Alcantar JM, Smith JB, Detels R, Martínez-Maza O.

AIDS Res Treat. 2010;2010:164586. doi: 10.1155/2010/164586. Epub 2010 Aug 25.

PMID:
21490903
Free PMC Article
14.

EBV and HIV-Related Lymphoma.

Bibas M, Antinori A.

Mediterr J Hematol Infect Dis. 2009 Dec 29;1(2):e2009032. doi: 10.4084/MJHID.2009.032.

15.

Introducing mediterranean journal of hematology and infectious diseases.

Leone G, Larocca LM, Pizzigallo E.

Mediterr J Hematol Infect Dis. 2009 Jun 17;1(1):e2009001. doi: 10.4084/MJHID.2009.001.

16.

Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.

See AP, Zeng J, Tran PT, Lim M.

Radiat Oncol. 2011 Mar 17;6:25. doi: 10.1186/1748-717X-6-25.

17.

Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution.

Huhn GD, Badri S, Vibhakar S, Tverdek F, Crank C, Lubelchek R, Max B, Simon D, Sha B, Adeyemi O, Herrera P, Tenorio A, Kessler H, Barker D.

AIDS Res Ther. 2010 Dec 14;7:44. doi: 10.1186/1742-6405-7-44.

18.

Hodgkin's Disease in Patients with HIV Infection.

Spina M, Carbone A, Gloghini A, Serraino D, Berretta M, Tirelli U.

Adv Hematol. 2011;2011. pii: 402682. doi: 10.1155/2011/402682. Epub 2010 Sep 23.

19.

Burkitt's lymphoma mimicking EBV disease as first sign of vertical HIV infection in an adolescent.

Santilli V, Mora N, Aquilani A, Tchidjou HK, Pontrelli G, De Vito R, Lombardi A, Bernardi S, Palma P.

Ital J Pediatr. 2010 Apr 23;36:34. doi: 10.1186/1824-7288-36-34.

20.

Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma.

Salemi M, Lamers SL, Huysentruyt LC, Galligan D, Gray RR, Morris A, McGrath MS.

PLoS One. 2009 Dec 3;4(12):e8153. doi: 10.1371/journal.pone.0008153.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk